Leadership Overview
Fresenius Kabi has 9 executives leading key functions including technology, finance, operations, business development, marketing, and regional leadership.
Driven by a commitment to improving patient lives, Fresenius Kabi specializes in medicines and technologies for infusion, transfusion, and clinical nutrition, impacting global healthcare.
Driven by a commitment to improving patient lives, Fresenius Kabi specializes in medicines and technologies for infusion, transfusion, and clinical nutrition, impacting global healthcare.
Leadership Roles at Fresenius Kabi
Marco Magrassi - Chief Financial Officer
Marco Magrassi, the Chief Financial Officer at Fresenius Kabi, oversees all financial operations and strategic financial planning. Magrassi manages the company's fiscal health, ensuring robust financial controls and driving profitable growth across global markets. This role involves capital allocation, investment strategies, and financial reporting to stakeholders. The Chief Financial Officer's expertise is crucial in navigating the complex financial landscape of the global healthcare sector, supporting Fresenius Kabi's specialization in infusion, transfusion, and clinical nutrition. Marco Magrassi's leadership ensures financial stability and enables the expansion of critical medical technologies and medicines.
Kaushal Gupta - Chief Financial Officer & Vice President
Kaushal Gupta, the Chief Financial Officer & Vice President at Fresenius Kabi, manages critical financial functions and contributes to strategic leadership. Gupta oversees financial planning, analysis, and reporting, ensuring fiscal discipline and supporting growth initiatives. This dual role involves driving financial performance and contributing to the overall strategic direction of the company, particularly within its specialized areas of infusion, transfusion, and clinical nutrition. The Chief Financial Officer & Vice President's financial acumen is vital for resource allocation and investment decisions. Kaushal Gupta's leadership ensures the financial integrity and strategic advancement of Fresenius Kabi's global operations.
Alex Garini - Executive Vice President & Chief Financial Officer
Alex Garini, the Executive Vice President & Chief Financial Officer at Fresenius Kabi, directs comprehensive financial strategies and oversees fiscal management for the organization. Garini is instrumental in financial planning, investment analysis, and ensuring the financial health of Fresenius Kabi's global operations. This executive leadership role involves managing capital resources and driving financial performance across the company's specialized sectors of infusion, transfusion, and clinical nutrition. The Executive Vice President & Chief Financial Officer's strategic financial guidance supports the company's mission to deliver essential medicines and technologies. Alex Garini's leadership ensures robust financial frameworks for sustained growth and operational excellence.
Rakesh Patel - Chief Operating Officer
Rakesh Patel, the Chief Operating Officer at Fresenius Kabi, directs the company's global operational strategies and execution. Patel is responsible for optimizing manufacturing processes, supply chain management, and ensuring the efficient delivery of Fresenius Kabi's specialized medicines and technologies. This leadership position involves enhancing operational excellence across all facilities worldwide, aligning with the company's focus on infusion, transfusion, and clinical nutrition. The Chief Operating Officer's oversight ensures product quality and availability, supporting the company's mission to improve patient outcomes. Rakesh Patel drives operational efficiency to meet the growing global demand for essential healthcare solutions.
Takaaki Okado - Representative Director and President
Takaaki Okado, the Representative Director and President at Fresenius Kabi, holds ultimate responsibility for the company's strategic direction and overall performance. Okado leads the executive team in advancing Fresenius Kabi's mission to provide critical medicines and technologies for infusion, transfusion, and clinical nutrition. This presidential role involves overseeing global operations, fostering innovation, and ensuring alignment with corporate objectives. The Representative Director and President's vision guides the company's expansion and commitment to improving patient care worldwide. Takaaki Okado's leadership ensures Fresenius Kabi maintains its position as a global healthcare leader.
Jonny Ducker - President, Region (North America)
Jonny Ducker, the President, Region (North America) at Fresenius Kabi, directs all operations and strategic initiatives within the North American market. Ducker is responsible for driving business growth, expanding market presence, and ensuring the successful delivery of Fresenius Kabi's specialized healthcare solutions across the region. This leadership role involves overseeing sales, marketing, and operational functions to meet the specific needs of North American healthcare providers. The President, Region (North America)'s focus is on strengthening Fresenius Kabi's impact in infusion, transfusion, and clinical nutrition. Jonny Ducker's leadership ensures regional alignment with global objectives and enhances patient access to vital medical technologies.
Scott Meacham - President, Pharmaceuticals (USA)
Scott Meacham, the President, Pharmaceuticals (USA) at Fresenius Kabi, leads the pharmaceutical division within the United States, driving its strategic growth and operational execution. Meacham oversees the development, manufacturing, and commercialization of Fresenius Kabi's pharmaceutical products, focusing on infusion, transfusion, and clinical nutrition therapies. This critical role involves ensuring compliance with regulatory standards and expanding market access for essential medicines. The President, Pharmaceuticals (USA)'s leadership is vital for advancing the company's mission to improve patient outcomes through innovative pharmaceutical solutions. Scott Meacham's expertise guides the US pharmaceutical operations toward sustained success and market leadership.
Vaibhav Pimpale - Chief Technology Officer
Vaibhav Pimpale, the Chief Technology Officer at Fresenius Kabi, directs the company's technological strategy and innovation. Overseeing the development and implementation of advanced technological solutions, Pimpale ensures that Fresenius Kabi remains at the forefront of medical technology. This leadership involves managing the IT infrastructure, cybersecurity protocols, and digital transformation initiatives critical to the company's global operations. By driving technological advancements, the Chief Technology Officer supports the company's mission to provide essential medicines and technologies for infusion, transfusion, and clinical nutrition. Vaibhav Pimpale's focus is on enhancing operational efficiency and expanding the reach of Fresenius Kabi's life-saving products worldwide.
Katherine Luterek - Senior Business Development Manager & Chief Marketing Officer, Sterile Fill Finish
Katherine Luterek, the Senior Business Development Manager & Chief Marketing Officer, Sterile Fill Finish at Fresenius Kabi, spearheads strategic growth initiatives and marketing efforts for sterile fill finish operations. Luterek identifies new market opportunities and develops strategies to enhance Fresenius Kabi's position in the specialized field of sterile drug manufacturing. This leadership role involves cultivating key partnerships and driving market penetration for critical infusion and transfusion technologies. The Senior Business Development Manager & Chief Marketing Officer, Sterile Fill Finish's expertise ensures that Fresenius Kabi's advanced solutions reach healthcare providers effectively. Katherine Luterek's focus is on expanding market share and driving innovation in sterile fill finish processes.
Explore Leadership Teams in Manufacturing
Sanofi is a global biopharmaceutical company dedicated to improving lives through scientific innovation. The company focuses on discovering, developing, and delivering medicines and vaccines across immunology, rare diseases, neurology, oncology, and preventive care. Guided by research and patient needs, it works with healthcare partners worldwide to advance sustainable and responsible healthcare solutions.
Company Leadership AH
EH
JB
DS
Johnson & Johnson is a global healthcare company that develops pharmaceuticals and medical technologies. It provides innovative medicines, surgical products, and medical devices used in areas such as oncology, immunology, neuroscience, and cardiovascular care, serving healthcare providers and patients worldwide.
Company Leadership
NM
DP
Bristol-Myers Squibb operates as a global biopharmaceutical organization dedicated to discovering, developing, and manufacturing prescription medications that address serious patient needs across multiple therapeutic domains. The company's scientific expertise spans oncology, cardiovascular disease, immunoscience, and virology, with particular depth in treating complex conditions including HIV and cancer. Through sustained investment in research and development, the organization has built a comprehensive medication portfolio that combines innovative cancer immunotherapies, anticoagulant therapies, and treatments for chronic viral infections. The company's operational footprint extends across major markets worldwide, enabling efficient distribution and patient access to its therapeutic solutions. Bristol-Myers Squibb pursues a collaborative approach to medical innovation, actively engaging in research partnerships and strategic alliances that accelerate the development of new treatment options. This commitment to external collaboration complements the organization's internal capabilities, creating a dynamic environment where scientific breakthroughs can translate into meaningful therapeutic advances. Bristol-Myers Squibb's medication portfolio reflects decades of pharmaceutical expertise and a strategic focus on disease areas where unmet medical needs remain significant.
Company Leadership BT
DG
KK
Founded in 1987, Integrated DNA Technologies, Inc. headquartered in Coralville, Iowa, is the supplier of custom nucleic acids, serving the areas of academic research, biotechnology, clinical diagnostics, and pharmaceutical development. The company develops, manufactures, and markets nucleic acid products for the life sciences industry.
Company Leadership AA
CL
AG
AM
Frequently Asked Questions Regarding Fresenius Kabi Top Executives and Leadership Team
Unlock more people and company data
